InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Update

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 124,000 shares, an increase of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Price Performance

Shares of InnoCare Pharma stock remained flat at $1.55 during trading hours on Monday. InnoCare Pharma has a 12-month low of $1.55 and a 12-month high of $2.31. The stock’s 50-day moving average price is $1.55 and its 200-day moving average price is $1.58.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley raised InnoCare Pharma to an “overweight” rating in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

InnoCare Pharma Company Profile

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation.